Vielight Inc.: Clinical Trials

7 trials sponsored by Vielight Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 not yet recruiting, 2 unknown, 1 suspended. 5 Not applicable, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Not yet recruiting 2, Completed 1, Suspended 1, Unknown 1
Early Phase 11Unknown 1
Phase 11Completed 1

Follow Vielight Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Photobiomodulation, Heart Rate Variability, and Acute Stress
Vielight Vagus, Sham Vielight Vagus - Stress
Not applicableNot yet recruitingBrigham and Women's Hospital402026-11-012026-09-24
Transcranial Photobiomodulation for Bipolar Depression
Vielight Neuro Rx Gamma, Sham Device - Bipolar, Bipolar Disorder (BD)
Not applicableNot yet recruitingVielight Inc.402026-07-012026-04-03
A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment
Vielight Neuro RX Gamma active device, Vielight Neuro RX Gamma sham device - Post COVID-19 Cognitive Impairment
Phase 1CompletedVielight Inc.362023-04-012025-06-15
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms
Vielight RX Plus - COVID-19
Not applicableUnknownVielight Inc.2952020-09-022021-06-14
Photobiomodulation to Improve Cognition in TBI, With fMRI
Real LED Intervention, Sham LED Intervention - Traumatic Brain Injury, Closed Head Injury
Early Phase 1UnknownBoston VA Research Institute, Inc.202019-08-072022-02-25
Neuro RX Gamma - Pivotal Phase
Active Neuro RX Gamma device, Sham Neuro RX Gamma device - Alzheimer Disease
Not applicableSuspendedVielight Inc.2282019-06-262023-01-25
Vielight Neuro RX Gamma - Feasibility Pilot
Neuro RX Gamma synchronous, Sham, Neuro RX Gamma asynchronous - Alzheimer Disease
Not applicableCompletedVielight Inc.602017-12-042023-01-25

Conditions studied

Alzheimer Disease (2)  ·  Bipolar Disorder (1)  ·  Brain Injuries, Traumatic (1)  ·  COVID-19 (1)  ·  Cognitive Dysfunction (1)  ·  Head Injuries, Closed (1)  ·  Stress Disorders, Post-Traumatic (1)

Interventions

Low-Level Light Therapy (1)  ·  Therapeutics (1)

Countries

Canada (4)  ·  United States (4)

Top investigators

Corinne Fischer, MD (1)  ·  Paula I Martin, PhD (1)  ·  Peter Wayne (1)

Results publications

PMID 38940733, PMID 41768981